Prostaglandin E2 activates cAMP response element-binding protein in glioma cells via a signaling pathway involving PKA-dependent inhibition of ERK
被引:19
作者:
Bidwell, Philip
论文数: 0引用数: 0
h-index: 0
机构:
Methodist Res Inst, Signal Transduct Lab, Indianapolis, IN 46202 USAMethodist Res Inst, Signal Transduct Lab, Indianapolis, IN 46202 USA
Bidwell, Philip
[1
]
Joh, Kiwon
论文数: 0引用数: 0
h-index: 0
机构:
Methodist Res Inst, Signal Transduct Lab, Indianapolis, IN 46202 USAMethodist Res Inst, Signal Transduct Lab, Indianapolis, IN 46202 USA
Joh, Kiwon
[1
]
Leaver, H. Anne
论文数: 0引用数: 0
h-index: 0
机构:
Univ Edinburgh, Dept Clin Neurosci, Edinburgh, Midlothian, ScotlandMethodist Res Inst, Signal Transduct Lab, Indianapolis, IN 46202 USA
Leaver, H. Anne
[3
]
Rizzo, Maria Teresa
论文数: 0引用数: 0
h-index: 0
机构:
Methodist Res Inst, Signal Transduct Lab, Indianapolis, IN 46202 USA
Indiana Univ, Sch Med, Dept Pharmacol, Indianapolis, IN 46202 USAMethodist Res Inst, Signal Transduct Lab, Indianapolis, IN 46202 USA
Rizzo, Maria Teresa
[1
,2
]
机构:
[1] Methodist Res Inst, Signal Transduct Lab, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Dept Pharmacol, Indianapolis, IN 46202 USA
Prostaglandin E-2 (PGE(2)) plays a Critical role in influencing the biological behavior of tumor cells. We previously demonstrated that PGE(2) stimulates human glioma cell growth via activation of protein kinase A (PKA) type II. This study was undertaken to further elucidate the intracellular pathways activated by PGE(2) downstream to PKA. Stimulation of U87-MG glioma cells with PGE(2) increased phosphorylation of the cyclic-AMP response element (CRE) binding protein CREB at Ser-133 and CREB-driven transcription in a dose- and time-dependent manner. Expression of dominant CREB constructs that interfere with CREB phosphorylation at Ser-133 or with its binding to the CRE site markedly decreased PGE(2)-induced CREB activation. Inhibition of PKA by H-89 or expression of a dominant negative PKA construct attenuated PGE(2)-induced CREB activation. Moreover, inhibition of PKA type II decreased PGE(2)-induced CREB-dependent transcription by 45% compared to vehicle-treated cells. To investigate the involvement of additional signaling pathways, U87-MG cells were pretreated with wortmannin or LY294002 to inhibit the PI3-kinase/AKT pathway. Both inhibitors had no effect on PGE(2)-induced CREB phosphorylation and transcriptional activity, suggesting that PGE(2) activates CREB in a PI3-kinase/AKT independent manner. Challenge of U87-MG cells with PGE(2). at concentrations that induced maximal CREB activation, or with forskolin inhibited extracellular signal-regulated kinase (ERK) phosphorylation. Pretreatment of U87-MG cells with the ERK inhibitor PD98059, accentuated ERK inhibition and increased CREB phosphorylation at Ser-133 and CREB-driven transcription stimulated by PGE(2), Suggesting that inhibition of ERK contributes to PGE(2)-induced CREB activation. Inhibition of ERK by PGE(2) or by forskolin was rescued by treatment of cells with H-89 or by the dominant negative PKA construct. Moreover, PGE(2) or forskolin inhibited phosphorylation of Raf-1 phosphorylation at Ser-338. Challenge of U87-MG cells with 11-deoxy-PGE(1) increased CREB-driven transcription and stimulated cell growth, while other PGE(2) analogues had no effect. Together our results reveal a novel signaling pathway whereby PGE(2) signals through PKA to inhibit ERK and increase CREB transcriptional activity. (C) 2009 Elsevier Inc. All rights reserved.